The Johns Hopkins Bloomberg School of Public Health is the public health graduate school of Johns Hopkins University in Baltimore, Maryland.

During the past decade, Johns Hopkins Bloomberg School of Public Health conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 7 clinical trials were completed, i.e. on average, 25.9% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 2 clinical trials were completed. i.e. 18.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Johns Hopkins Bloomberg School of Public Health" #1 sponsor was "Johns Hopkins Bloomberg School of Public Health" with 42 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 15 trials sponsored, "National Human Genome Research Institute (NHGRI)" with 3 trials sponsored, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 2 trials sponsored and "University of Florida" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Johns Hopkins Bloomberg School of Public Health" #1 collaborator was "National Institute of Mental Health (NIMH)" with 6 trials as a collaborator, "Bill and Melinda Gates Foundation" with 5 trials as a collaborator, "National Institute on Drug Abuse (NIDA)" with 5 trials as a collaborator, "Johns Hopkins Bloomberg School of Public Health" with 4 trials as a collaborator and "National Institutes of Health (NIH)" with 4 trials as a collaborator. Other collaborators include 61 different institutions and companies that were collaborators in the rest 62 trials.

According to Clinical.Site data, the most researched conditions in "Johns Hopkins Bloomberg School of Public Health" are "Obesity" (6 trials), "HIV Infections" (5 trials), "Breast Cancer" (3 trials), "Prostate Cancer" (3 trials) and "Beliefs" (2 trials). Many other conditions were trialed in "Johns Hopkins Bloomberg School of Public Health" in a lesser frequency.

Most popular intervention types in "Johns Hopkins Bloomberg School of Public Health" are "Behavioral" (34 trials), "Biological" (15 trials), "Other" (13 trials), "Drug" (8 trials) and "Dietary Supplement" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Adapted FOY+ImPACT" (1 trials), "BCCU" (1 trials), "Best-Worst Scaling (Case 1)" (1 trials) and "Best-Worst Scaling (Case 2)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Johns Hopkins Bloomberg School of Public Health" are 63 trials for "All" genders, 6 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Johns Hopkins Bloomberg School of Public Health". undefined are not yet recruiting, 8 are recruiting, 1 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 54 completed trials in Johns Hopkins Bloomberg School of Public Health, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Johns Hopkins Bloomberg School of Public Health, 14 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 35 trials that are defined as “Not Applicable".